Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study.
Wémeau JL, Caron P, Beckers A, Rohmer V, Orgiazzi J, Borson-Chazot F, Nocaudie M, Perimenis P, Bisot-Locard S, Bourdeix I, Dejager S. Wémeau JL, et al. Among authors: bourdeix i. J Clin Endocrinol Metab. 2005 Feb;90(2):841-8. doi: 10.1210/jc.2004-1334. Epub 2004 Nov 23. J Clin Endocrinol Metab. 2005. PMID: 15562016 Free article. Clinical Trial.
Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
Fénelon G, Giménez-Roldán S, Montastruc JL, Bermejo F, Durif F, Bourdeix I, Péré JJ, Galiano L, Schadrack J. Fénelon G, et al. Among authors: bourdeix i. J Neural Transm (Vienna). 2003 Mar;110(3):239-51. doi: 10.1007/s00702-002-0799-z. J Neural Transm (Vienna). 2003. PMID: 12658373 Clinical Trial.
32 results